Cordova Ashley 4
4 · NovoCure Ltd · Filed Aug 5, 2024
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Cordova Ashley
Former Chief Executive Officer
Transactions
- Sale
Ordinary Shares
2024-08-02$20.14/sh−688$13,857→ 219,179 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.